Comparing corticosteroid and PRP injections for shoulder arthritis treatment
Official title: Prospective, Double Blind, Randomized Control Trial Comparing the Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis
Run by Rush University Medical Center · NCT04949087 · Data updated 2026-11-12
This study tests whether corticosteroid injections or PRP injections work better to relieve pain for people with shoulder arthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Rush University Medical Center Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | March 13, 2023 |
| Main results expected | January 2027 |
| Study ends | January 2028 |
| Registry record updated | February 17, 2026 |
| Trial ID | NCT04949087 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a diagnosis of primary glenohumeral arthritis and a pain level greater than 4 on the VAS scale.
✕Probably not a fit
Patients with secondary causes of arthritis or recent shoulder surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of intra-articular corticosteroid injections compared to platelet-rich plasma (PRP) injections for treating primary glenohumeral osteoarthritis. It focuses on patients who have been diagnosed with this condition and are experiencing significant pain. The goal is to provide symptomatic relief and potentially delay the need for shoulder surgery. By comparing these two treatment options, the study seeks to clarify their therapeutic benefits in managing shoulder arthritis.
Why it matters
Potential benefit: If successful, this study could offer patients effective non-surgical treatment options for shoulder arthritis, improving their quality of life.
How similar studies have gone: Other studies have shown promising results with similar injection therapies for joint pain, suggesting potential efficacy for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient ≥18y.o. of age * Primary glenohumeral arthritis (bone on bone or near bone on bone) that has been previously diagnosed on radiographs and clinical evaluation. * Baseline pain level of VAS \>4 Exclusion Criteria: * Secondary causes of arthritis (i.e. septic arthritis, rheumatoid arthritis, rotator cuff arthropathy, post-traumatic arthritis) * Ipsilateral shoulder surgery within 1 year * Any glenohumeral joint injection within 3 months * Allergy to lidocaine * Known pregnancy * Workers compensation case regarding shoulder
Where it's running
-
Rush University Medical Center
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Carla M Edwards, PhD
- Email: carla_edwards@rush.edu
- Phone: 312.563.5735
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating the Zimmer Biomet Shoulder Replacement System
This study is testing how safe and effective the Zimmer Biomet Shoulder Replacement System is for people getting shoulder surgery, looking at their pain, movement, and quality of life over two years.
-
Comparing two shoulder surgeries for arthritis treatment
This study is testing whether a new type of shoulder surgery can help people with arthritis just as much as the standard surgery over two years.
-
Pharmacist-led blood pressure care delivered in Chicago neighborhoods
This program tests whether a mobile pharmacist-led team can help adults with uncontrolled high blood pressure on Chicago's West and South Sides lower their blood pressure when care is offered in trusted community settings.
-
Paracervical Block With Ketorolac and Lidocaine for Osmotic Dilator Placement
This study tests whether a ketorolac and lidocaine injection around the cervix improves pain control for people needing osmotic dilators before a second-trimester abortion.
-
PTSD treatment delivered by your primary care nurse
This will test whether nurses trained to deliver a short, four-session trauma therapy can help primary care patients who develop PTSD after a recent life-threatening heart or stroke event.
-
Holmium laser versus electrohydraulic lithotripsy for difficult bile duct and pancreatic duct stones
This will test whether a low-power holmium laser works and is as safe as electrohydraulic lithotripsy for adults with large or hard-to-remove bile duct or pancreatic duct stones.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.